N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
NAT2 genotyping individualization of isoniazid treatment Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010
Detection of isoniazid resistance mutations in Mycobacterium tuberculosis by use of sequencing, PCR-RFLP and TaqMan probes Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Association between N-acetyltransferase 2 polymorphism and antituberculosis drug-induced liver injury risk: a meta-analysis Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Determination of the six polymorphisms in the NAT2 gene helps to predict isoniazid side effects. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021
Risk of antituberculosis drug (ATD)-induced hepatotoxicity and polymorphisms at the glutatione S-transferase (GST) loci (GSTM1 and GSTT1) Source: Eur Respir J 2006; 28: Suppl. 50, 342s Year: 2006
The influence phenotype of hydroxylation on anti-tuberculosis drug-induced hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006
Detection of rifampin resistance mutations in Mycobacterium tuberculosis by use of sequencing, molecular beacons and taqman probes Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Progression towards the development of the universal highly discriminative panel of VNTR loci for mycobacterium tuberculosis genotyping Source: Eur Respir J 2006; 28: Suppl. 50, 525s Year: 2006
Evaluation of ANXA11 rs1049550 SNP linkage with sarcoidosis susceptibility Source: Annual Congress 2012 - Sarcoidosis Year: 2012
Genetic polymorphism of epoxide hydrolase and GSTM1 in lung cancer susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002
Relationship of interleukin 10 1082 G/A gene polymorphism with the duration of nephrotoxic onset due to anti tuberculosis drugs in multi drug resistant tuberculosis patients Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
Genetic GST and NAT polymorphism and diisocyanate-induced asthma Source: Eur Respir J 2001; 18: Suppl. 33, 2s Year: 2001
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs Source: Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020 Year: 2021
Genetic polymorphism of NAT-2 gene in adolescents with variable course of infiltrative tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007
Biochip analysis of xenobiotic-metabolizing gene polymorphisms in children with bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Predicting the efficiency of the treatment of drug-resistant tuberculosis depending on the polymorphism variation of glutathione-S-transferase genes Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
TNF-α promoter polymorphisms analysis in the susceptibility to beryllium-hypersensitivity Source: Eur Respir J 2003; 22: Suppl. 45, 186s Year: 2003
Rapid detection of M. tuberculosis gene mutations associated with drug resistance by modified allele-specific real-time PCR Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006